BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7678457)

  • 1. In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chain.
    Rostaing-Capaillon O; Casellas P
    Cancer Immunol Immunother; 1991; 34(1):24-30. PubMed ID: 1722138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo properties of an anti-CD5-momordin immunotoxin on normal and neoplastic T lymphocytes.
    Porro G; Bolognesi A; Caretto P; Gromo G; Lento P; Mistza G; Sciumbata T; Stirpe F; Modena D
    Cancer Immunol Immunother; 1993 May; 36(5):346-50. PubMed ID: 7682894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry Using Electron Capture Dissociation and Ultraviolet Photodissociation.
    Shaw JB; Liu W; Vasil Ev YV; Bracken CC; Malhan N; Guthals A; Beckman JS; Voinov VG
    Anal Chem; 2020 Jan; 92(1):766-773. PubMed ID: 31769659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs.
    Muchekehu R; Liu D; Horn M; Campbell L; Del Rosario J; Bacica M; Moskowitz H; Osothprarop T; Dirksen A; Doppalapudi V; Kaspar A; Pirie-Shepherd SR; Coronella J
    Transl Oncol; 2013; 6(5):562-72. PubMed ID: 24151537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current strategies for protein production and purification enabling membrane protein structural biology.
    Pandey A; Shin K; Patterson RE; Liu XQ; Rainey JK
    Biochem Cell Biol; 2016 Dec; 94(6):507-527. PubMed ID: 27010607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing functional expression of heterologous lipase B in Escherichia coli by extracellular secretion.
    Narayanan N; Khan M; Chou CP
    J Ind Microbiol Biotechnol; 2010 Apr; 37(4):349-61. PubMed ID: 20039191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokaryotic expression and renaturation of engineering chimeric Fab antibody against human hepatoma.
    Xing JL; Yang XM; Yao XY; Song F; Chen ZN
    World J Gastroenterol; 2004 Jul; 10(14):2029-33. PubMed ID: 15237428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.
    Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Heymann S; Little M
    Cell Biophys; 1995 Jun; 26(3):187-204. PubMed ID: 8521451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates.
    Fishwild DM; Wu HM; Carroll SF; Bernhard SL
    Clin Exp Immunol; 1994 Jul; 97(1):10-8. PubMed ID: 8033405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.
    Better M; Bernhard SL; Lei SP; Fishwild DM; Lane JA; Carroll SF; Horwitz AH
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):457-61. PubMed ID: 7678457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mice.
    Kohn FR; Fishwild DM; Bernhard SL; Better M; Kung AH
    Int J Immunopharmacol; 1993 Nov; 15(8):871-8. PubMed ID: 7504661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxin.
    Siegall CB; Gawlak SL; Chin JJ; Zoeckler ME; Kadow KF; Brown JP; Braslawsky GR
    Bioconjug Chem; 1992; 3(4):302-7. PubMed ID: 1390985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
    Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.